Lopinavir Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections / Pregnant State Prevention

Indications	Status	Purpose	Phase
DBCOND0035016 (Human Immunodeficiency Virus (HIV) Infections) DBCOND0056919 (Pregnant State)	Completed	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women	Ethinylestradiol (DB00977) Lopinavir (DB01601) Norelgestromin (DB06713) Ritonavir (DB00503)